Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: Correction by glucocorticoid therapy
- 30 June 1981
- journal article
- case report
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 98 (6), 919-922
- https://doi.org/10.1016/s0022-3476(81)80588-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess.JCI Insight, 1980
- The Importance of Circulating 1,25-Dihydroxyvitamin D in the Pathogenesis of Hypercalciuria and Renal-Stone Formation in Primary HyperparathyroidismThe New England Journal of Medicine, 1980
- Evidence that Increased Circulating 1α,25-Dihydroxyvitamin D is the Probable Cause for Abnormal Calcium Metabolism in SarcoidosisJCI Insight, 1979
- 1, 25-DIHYDROXYCHOLECALCIFEROL IN THE PATHOGENESIS OF THE HYPERCALCÆMIA OF SARCOIDOSISThe Lancet, 1979
- REDUCED SERUM 1,25‐(OH)2 VITAMIN D3 LEVELS IN PREDNISONE‐TREATED ADOLESCENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSActa Paediatrica, 1979
- REDUCTION OF SERUM-1,25-DIHYDROXYVITAMIN-D3 IN CHILDREN RECEIVING GLUCOCORTICOIDSThe Lancet, 1978
- Radioimmunoassay of human parathyroid hormone in serumJCI Insight, 1971
- Sarcoidosis in children: With special emphasis on the natural history and treatmentThe Journal of Pediatrics, 1968
- On the abnormal calcium absorption in sarcoidosis: Evidence for increased sensitivity to vitamin DAmerican Journal Of Medicine, 1964
- EFFECT OF CORTISONE ON CALCIUM METABOLISM IN SARCOIDOSIS WITH HYPERCALCqMIA POSSIBLY ANTAGONISTIC ACTIONS OF CORTISONE AND VITAMIN DThe Lancet, 1954